37th week of 2014 patent applcation highlights part 63 |
Patent application number | Title | Published |
20140256770 | PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR - The invention provides a process for the preparation of a compound of Formula 1, | 2014-09-11 |
20140256771 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | 2014-09-11 |
20140256772 | PHARMACEUTICAL COMPOSITIONS THAT INHIBIT DISPROPORTIONATION - Pharmaceutical formulations comprising solid pharmaceutically acceptable organic acids, such as maleic acid or tartaric acid, that inhibit the disproportionation of pharmaceutically acceptable acid salts of active pharmaceutical ingredients, and methods of manufacturing such pharmaceutical compositions. The pharmaceutically acceptable acid salt of the active pharmaceutical ingredient has a pKa of less than about 6.0, and wherein the solid pharmaceutically acceptable organic acid has a pKa of less than about 4.0 and an aqueous solubility in the range of about 500 to about 2000 milligrams per milliliter. A pharmaceutical formulation comprising a pharmaceutical acceptable acid salt of pioglitazone, a solid pharmaceutically acceptable organic acid selected from the group consisting of maleic acid or tartaric acid, and an excipient that promotes disproportionation, wherein the ratio by weight of the solid pharmaceutically acceptable organic acid to excipient is from about 1:6 to about 1:1. | 2014-09-11 |
20140256773 | Novel nicotine derivatives - Described are novel nicotine derivatives represented by general formulas (I) and (III), and salts thereof, and herbicide & pharmaceutical compositions containing the same as the active ingredient. The compound and salts thereof can control annual or perennial weed growing on the land where various crops such as rice plant, wheat, cotton and corn grow for a wide period ranging from the pre-emergence to growth in a remarkably small dose. The compounds and salts thereof can be useful as an anti-microbial and anti-fungal agents and also for the treatment of blood pressure, skeletal muscle, attention deficit disorder, mental disorders, schizophrenia, Alzheimer disease, Parkinson's disease and depression. Also described is the preparation of the nicotine derivatives having formula (I) and (III). | 2014-09-11 |
20140256774 | METHODS FOR TREATING INFLAMMATION AND HYPERTENSION WITH GAMMA-KETOALDEHYDE SKAVENGERS - A method of treating at least one of inflammation, psoriasis, and/or hypertension comprising administering to a patient in need there of an effective gamma-ketoaldehyde scavenging amount of a gamma-ketoaldehyde scavenging compound. | 2014-09-11 |
20140256775 | NOVEL TRANSCRIPTION FACTOR MODULATORS - The present disclosure provides novel compounds capable of functioning as transcription factor modulators, as well as compositions, pharmaceutical formulations, and kits. Also provided are methods of treating a condition regulatable by a transcription factor and/or cofactor using the compounds, compositions, pharmaceutical formulations, and kits provided herein. | 2014-09-11 |
20140256776 | TREATMENT OF CANCER AND OTHER CONDITIONS USING A TRANSCRIPTION FACTOR MODULATOR - The present disclosure provides novel methods for treating cancer and conditions regulatable by a transcription factor and/or cofactor using specific compounds, as well as compositions, and pharmaceutical formulations. In certain embodiments, the compounds are transcription factor modulators. | 2014-09-11 |
20140256777 | BIOCIDAL COMPOSITION OF 2,6-DIMETHYL-M-DIOXANE-4-OL ACETATE AND METHODS OF USE - Provided is a biocidal composition comprising 2,6-dimethyl-m-dioxane-4-ol acetate and an isothiazolinone biocidal compound. The composition is useful for controlling microorganisms in aqueous or water containing systems. | 2014-09-11 |
20140256778 | HIGH AFFINITY BETA LACTAMASE INHIBITORS - Inhibitors of beta lactamases and their use in treating bacterial infections are disclosed. | 2014-09-11 |
20140256780 | PYRAZOLE DERIVATIVES AS MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY - The present invention provides compounds having formula (I): | 2014-09-11 |
20140256781 | Novel Formulation of Indomethacin - The present invention relates to methods for producing particles of indomethacin using dry milling processes as well as compositions comprising indomethacin, medicaments produced using indomethacin in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of indomethacin administered by way of said medicaments. | 2014-09-11 |
20140256782 | Opsin-Binding Ligands, Compositions and Methods of Use - Compounds are disclosed that are useful for treating ophthalmic conditions caused by or related to production of toxic is visual cycle products that accumulate in the eye, such as dry adult macular degeneration, as well as conditions caused by or related to the misfolding of mutant opsin proteins and/or the mis-localization of opsin proteins. Compositions of these compounds alone or in combination with other therapeutic agents are also described, along with therapeutic methods of using such compounds and/or compositions. Methods of synthesizing such agents are also disclosed. | 2014-09-11 |
20140256783 | SUBSTRATE AND METHOD FOR PRODUCTION THEREOF - The present invention relates to a substrate including a compound having blood anticoagulation activity and a hydrophilic polymer compound, wherein the amount of elution of the compound having blood anticoagulation activity is less than 0.6 μg/ml, and a manufacturing method of a substrate, wherein after a compound having blood anticoagulation activity and a hydrophilic compound brought in contact with a substrate are irradiated with radiation, unreacted components are washed out. | 2014-09-11 |
20140256784 | 4H-THIENO[3,2-C]CHROMENE-BASED INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE - Compounds that may be used to inhibit Notum Pectinacetylesterase are described, as well as compositions comprising them, and methods of their use to treat diseases and disorders affecting bone. | 2014-09-11 |
20140256785 | SITE SPECIFIC DELIVERY OF NUCLEIC ACIDS BY COMBINING TARGETING LIGANDS WITH ENDOSOMOLYTIC COMPONENTS - The invention relates to compositions and methods for site-specific delivery of nucleic acids by combining them with targeting ligands and endosomolytic components. | 2014-09-11 |
20140256786 | COMPOSITIONS AND METHODS FOR TREATMENT OF MITOCHONDRIAL DISEASES - Methods and compositions are provided for the treatment of a mitochondrial disease in an individual with the mitochondrial disease. Aspects of the methods include administering an inhibitor of a mitochondrial transport protein to a subject having a mitochondrial disease. Also provided are reagents and kits for practicing the subject methods. | 2014-09-11 |
20140256787 | COMPOSITIONS AND METHODS FOR SHORT INTERFERING NUCLEIC ACID INHIBITION OF Nav 1.8 - The invention provides short interfering nucleic acids, either single-stranded or double-stranded, that cause RNAi-induced degradation of mRNA from the Na.sub.v1.8 sodium channel gene; to pharmaceutical compositions comprising such short interfering nucleic acids; recombinant vectors comprising such short interfering nucleic acids; a method for inhibiting translation of an mRNA; a method for inhibiting expression of a polypeptide; a method for blocking the membrane potential in a cell; a method for blocking the sodium current in a cell; and a method for inhibiting chronic pain. | 2014-09-11 |
20140256788 | Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field - The invention relates to antisense oligonucleotidic sequences (ODN) against Smad7 suitably modified, and their uses in medical field as therapeutic biological agents, in particular in the treatment of chronic inflammatory bowel disease, such as Crohn's disease and ulcerative colitis. | 2014-09-11 |
20140256789 | COMPOSITION AND METHODS FOR MODULATING CELL PROLIFERATION AND CELL DEATH - Described herein are compositions and methods for modulation of p53-dependent cell death and cell proliferation. The compositions are microRNAs and associated nucleic acids. | 2014-09-11 |
20140256790 | Methods for Identifying and Compounds Useful for Increasing the Functional Activity and Cell Surface Expression of CF-Associated Mutant Cystic Fibrosis Transmembrance Conductance Regulator - The present invention relates to agents, and methods for identifying compounds, which agents and compounds result in the modulation of cellular trafficking of proteins in particular that of CF-associated mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). In addition, the invention relates to compositions and methods for the use thereof in treating conditions that are characterized by an ER-associated protein misfolding and abnormal cellular trafficking of disease-associated proteins, including cystic fibrosis (CF). | 2014-09-11 |
20140256791 | Compositions and Methods for Inhibiting Expression of XBP-1 Gene - The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting X-Box Protein 1 (XBP-1), and methods of using the dsRNA to inhibit expression of XBP-1. | 2014-09-11 |
20140256792 | COMPOUNDS FOR THE TREATMENT OF ISCHEMIC INJURY - The present invention relates to microRNA (miRNA) compounds for use in the treatment of consequences of acute ischemia/reperfusion, a method for preparing miRNA compounds by using test ischemic-reperfusion, test preconditioning and test postconditioning of biological samples, use of the miRNA compounds in the preparation of pharmaceutical compositions having cytoprotective and/or anti-ischemic effect in ischemic cardiac diseases. | 2014-09-11 |
20140256793 | MEDICAMENT FOR DISEASES ASSOCIATED WITH AMYLOID beta AND SCREENING THEREOF - The present invention is directed to providing a medicament for treating or preventing a condition, disorder or disease associated with amyloid β. Provided is a method for screening a medicament for treating or preventing a disease associated with amyloid β, the method comprising: A) subjecting at least one of elements selected from the group consisting of 1) exosome; 2) neutral sphingomyelinase 2 (N-SMase2); and 3) sphingomyelin synthetic enzyme 2 (SMS2), and a candidate of the medicament in a condition in which they can interact with each other; and B) examining an influence by the candidate of the medicament to the element, wherein at least one of the elements is used as an index for determining as to whether or not the candidate is the medicament. | 2014-09-11 |
20140256794 | ACTIVATION OF FUNCTIONAL NUCLEIC ACID BY SPECIFIC MODIFICATION - This invention is intended to enhance and improve the resistance of a single- or double-stranded nucleic acid fragment comprising a base sequence of a functional nucleic acid to degradation by nucleolytic enzymes in a simple and cost-effective manner. The single- or double-stranded nucleic acid fragment comprises, ligated to at least one 3′ end thereof, a hairpin-shaped DNA comprising: (A) a nucleic acid region consisting of 2 to 5 arbitrary nucleotides; (B) a nucleic acid region consisting of a “gna” or “gnna” base sequence, wherein each “n” represents “g”, “t”, “a”, or “c”, a base analogue, or a modified base; and (C) a nucleic acid region consisting of a base sequence complementary to the nucleic acid region (A), sequentially ligated from the 5′ end toward the 3′ end, wherein at least one of two 3′ terminal nucleotides from at least one 3′ end of the single-stranded nucleic acid fragment or the double-stranded nucleic acid fragment is modified. | 2014-09-11 |
20140256795 | CO-ACTIVATION OF MTOR AND STAT3 PATHWAYS TO PROMOTE NEURONAL SURVIVAL AND REGENERATION - Disclosed herein is a method of promoting sustained survival, sustained regeneration, in a lesioned mature neuron, sustained compensatory outgrowth in a neuron, or combinations thereof. The method comprises contacting the lesioned mature neuron with an effective amount of an inhibitor of PTEN and an effective amount of an inhibitor of SOCS3 to thereby promote survival and/or regeneration and/or compensatory outgrowth of the neuron. Therapeutic methods of treatment of a subject with a neuronal lesion by administration of a therapeutically effective amount of an inhibitor of PTEN and a therapeutically effective amount of an inhibitor of SOCS3, are also disclosed, as are pharmaceutical compositions and devices for use in the methods. | 2014-09-11 |
20140256796 | IN VITRO AND IN VIVO DELIVERY OF GENES AND PROTEINS USING THE BACTERIOPHAGE T4 DNA PACKAGING MACHINE - Described is T4 DNA packaging machine comprising: one or more DNA molecules packaged in a head of the T4 DNA packaging machine, one or more Hoc-fused proteins displayed on the head of the T4 DNA packaging machine, and one or more Soc-fused proteins displayed on the head of the T4 DNA packaging machine. Also described are methods of making and using such a T4 DNA packaging machine. | 2014-09-11 |
20140256797 | MODULATION OF TRANSTHYRETIN EXPRESSION - Provided herein are methods, compounds, and compositions for reducing expression of transthyretin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate transthyretin amyloidosis, or a symptom thereof. | 2014-09-11 |
20140256798 | TALEN-BASED GENE CORRECTION - The invention is directed to transcription activator-like effector nuclease (TALEN)-mediated DNA editing of disease-causing mutations in the context of the human genome and human cells to treat patients with compromised genetic disorders. | 2014-09-11 |
20140256799 | REPLICATION CAPABLE rAAV VECTORS ENCODING INHIBITORY siRNA AND METHODS OF THEIR USE - In some embodiments, an antiviral vector is provided. The antiviral vector includes a replication competent adeno-associated virus (AAV) and an inhibitory expression cassette that includes a nucleotide sequence that encodes an RNAi molecule that inhibits expression of a targeted helper virus (THV) gene. The THV gene may be part of an Adenovirus (Ad) genome, a Human Papillomavirus (HPV) genome, a Human Herpes Virus (HHV) genome, or a Vaccinia virus (W) genome. | 2014-09-11 |
20140256800 | FEV MINI-PROMOTERS - Isolated polynucleotides comprising a FEV mini-promoters are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, gene therapy, etc. | 2014-09-11 |
20140256801 | PERIPHERALLY DELIVERED GLUTAMIC ACID DECARBOXYLASE GENE THERAPY FOR SPINAL CORD INJURY PAIN - The invention provides a method of treating spinal cord injury pain or peripheral neuropathic pain in a mammal comprising administering to a mammal a vector comprising a nucleotide sequence encoding a glutamic acid decarboxylase (GAD) protein in an amount effective to treat spinal cord injury pain or peripheral neuropathic pain. | 2014-09-11 |
20140256802 | Dual-AAV Vector-Based Systems and Methods for Delivering Oversized Genes to Mammalian Cells - Disclosed are materials and methods for treating diseases of the mammalian eye, and in particular, Usher syndrome 1B (USH1B). The invention provides AAV-based, dual-vector systems that facilitate the expression of full-length proteins whose coding sequences exceed that of the polynucleotide packaging capacity of an individual AAV vector. In one embodiment, vector systems are provided that include i) a first AAV vector polynucleotide that includes an inverted terminal repeat at each end of the polynucleotide and a suitable promoter followed by a partial coding sequence that encodes an N-terminal portion of a full-length polypeptide; and ii) a second AAV vector polynucleotide that includes an inverted terminal repeat at each end of the polynucleotide and a partial coding sequence that encodes a C-terminal portion of a full-length polypeptide, optionally followed by a polyadenylation (pA) signal sequence. In another embodiment, the vector system includes i) a first AAV vector polynucleotide comprising an inverted terminal repeat at each end, a suitable promoter followed by a partial coding sequence that encodes an N-terminal portion of a full-length polypeptide followed by a splice donor site and intron and ii) a second AAV vector polynucleotide comprising an inverted terminal repeat at each end, followed by an intron and a splice-acceptor site for the intron, followed by a partial coding sequence that encodes a C-terminal portion of a full-length polypeptide, optionally followed by a polyadenylation (pA) signal sequence. The coding sequence or the intron sequence in the first and second AAV vectors preferably includes a sequence region that overlaps. | 2014-09-11 |
20140256803 | TUMOR NECROSIS FACTOR INHIBITORS - The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-α mediated conditions. | 2014-09-11 |
20140256804 | PHARMACEUTICAL COMPOSITION - The present invention provides a pharmaceutical composition which prevents from decreasing the blood exposure of the third generation coxib-drugs, a process for preparing the said pharmaceutical composition and its use. | 2014-09-11 |
20140256805 | NEUROACTIVE SUBSTITUTED CYCLOPENTA[b]PHENANTHRENES AS MODULATORS FOR GABA TYPE-A RECEPTORS - The present disclosure is generally directed to neuroactive substituted cyclopenta[b]phenanthrenes as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to GABA function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds. | 2014-09-11 |
20140256806 | PROPHYLACTIC AGENT FOR CHRONIC KIDNEY DISEASE - A method for ameliorating and/or preventing chronic kidney disease includes administering to a subject in need thereof an agent containing 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt thereof as an active ingredient. Preferably, these ALAs contain a metal-containing compound, such as sodium ferrous citrate. The above-mentioned ALAs, ALA; various esters, such as ALA methylester, ALA ethylester, ALA propylester, ALA butylester, and ALA pentylester; and hydrochlorides, phosphates, and sulfates, and the like of these ALA esters are preferred examples. | 2014-09-11 |
20140256807 | METHODS OF TREATMENT USING AMMONIA-SCAVENGING DRUGS - The invention provides a method for determining a dose and schedule and making dose adjustments of PBA prodrugs used to treat nitrogen retention states, or ammonia accumulation disorders, by measuring urinary excretion of phenylacetylglutamine and/or total urinary nitrogen. The invention provides methods to select an appropriate dosage of a PBA prodrug based on the patient's dietary protein intake, or based on previous treatments administered to the patient. The methods are applicable to selecting or modifying a dosing regimen for a subject receiving an orally administered ammonia scavenging drug. | 2014-09-11 |
20140256808 | Use of Ketogenic Compounds for Treatment of Age-Associated Memory Impairment - This invention relates to the field of therapeutic agents for the treatment of Age-Associated Memory Impairment (AAMI). In particular, the present invention utilizes compositions comprising at least one compound capable of elevating ketone body concentrations in a mammal (e.g., ketogenic compounds), administered in an amount effective for treatment or prevention of loss of cognitive function caused by reduced neuronal metabolism in AAMI. In one embodiment, the composition includes medium chain triglycerides (MCT). In another embodiment, the compositions are administered in the presence of carbohydrate. The present invention also relates to oral dosage forms, in particular, a nutritional drink comprising at least one compound capable of elevating ketone body concentrations in a mammal. | 2014-09-11 |
20140256809 | COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID AND A HYDROXYL COMPOUND AND METHODS OF USE THEREOF - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 2014-09-11 |
20140256810 | LOW MELTING PROPIONIC ACID DERIVATIVE PARTICLES FOR USE IN ORAL DOSAGE FORMS - Low melting propionic acid derivative particles that are free flowing and have significantly reduced or eliminated throat burn are disclosed. A method of manufacturing the low melting propionic acid derivative particles; dosage forms containing the low melting propionic acid derivative particles; methods of manufacturing the dosage forms; and methods of treatment using the dosage forms are also disclosed. | 2014-09-11 |
20140256811 | EFFICIENT STABILIZER IN CONTROLLING SELF ACCELERATED DECOMPOSITION TEMPERATURE OF PEROXYCARBOXYLIC ACID COMPOSITIONS WITH MINERAL ACIDS - Highly acidic, stabilized peroxycarboxylic acid compositions are disclosed as having both improved antimicrobial efficacy in comparison to conventional peroxyoctanoic acid and peroxyacetic acid compositions for sanitizing applications, and improved transport and shipping stability. In particular, low odor and low/no VOC compositions having dual functionality as both acid wash and sanitizing compositions are disclosed. | 2014-09-11 |
20140256812 | NOVEL ANTIMICROBIAL COMPOUNDS AND USES THEREOF - The present invention relates to novel antimicrobial compounds, methods of their production as well as uses thereof. | 2014-09-11 |
20140256813 | METHODS FOR THE TREATMENT OF BRAIN INJURY USING OMEGA-3 FATTY ACIDS - Methods of treating, managing or preventing brain injury are disclosed. Specific methods encompass the administration of EPA and DHA triglycerides for the treatment of brain injuries. | 2014-09-11 |
20140256814 | HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS - Activated fatty acids, pharmaceutical compositions including activated fatty acids, methods for using activated fatty acids to treat a variety of diseases, and methods for preparing activated fatty acids are provided herein. | 2014-09-11 |
20140256815 | USE OF NITRATED LIPIDS FOR TREATMENT OF SIDE EFFECTS OF TOXIC MEDICAL THERAPIES - The present invention relates to methods of treating the side effects of a toxic medical therapy using nitrated lipids. In particular, the methods comprise the use of nitrated fatty acids or esters thereof to treat side effects, including organ system damage, caused by chemotherapy, radiotherapy, and the administration of other toxic agents. | 2014-09-11 |
20140256816 | Adamantyl Derivatives as Therapeutic Agents - The present invention relates to adamantyl derivatives and their anti-cancer activity. Compounds of formulae I and II are provided as well as related methods of treatment and methods of synthesis. | 2014-09-11 |
20140256817 | AMPHIPATHIC AND OTHER DOUBLE-SIDED ALPHA-HELIX MIMETICS BASED ON A 1,2-DIPHENYLACETYLENE SCAFFOLD - Small-molecule scaffolds based on 1,2-diphenylacetylene that accurately replicate the spatial and angular projections of several side chains on both faces of an α-helix, specifically the i and i+7 side chains on one face, and the i and i+2 side chains on the other. The amphipathic α-helix mimetic can be used to disrupt disease-promoting protein-protein interactions that are mediated by α-helices. | 2014-09-11 |
20140256818 | NANO-SUSPENSION PROCESS - Described herein is a process for preparing nano-suspensions, wherein the process comprises: providing an admixture of at least one active pharmaceutical compound, an aqueous dispersion medium, and milling media and applying thereto acoustic energy having a frequency of from about 10 hertz to 1000 hertz and which supplies a linear acceleration of from about 10 G′s to about 100 G′s (where “G” is the force of gravity) for a period sufficient to supply a nano-suspension having a D | 2014-09-11 |
20140256819 | KINASE INHIBITORS - The present invention relates to compounds of formula I | 2014-09-11 |
20140256820 | THERAPEUTIC AGENT FOR BLOOD-BRAIN BARRIER DISRUPTION SYNDROME - A medicinal agent or a pharmaceutical composition, each of which comprises a biguanides agent or a pharmaceutically acceptable salt thereof as an active ingredient, and which can potentiate blood-brain barrier functions including tight junction capability and transcellular transport capability of a brain capillary endothelial cell and therefore can treat blood-brain barrier dysfunction syndrome. | 2014-09-11 |
20140256821 | INTRANNASAL ADMINISTRATION OF KETAMINE TO TREAT DEPRESSION - Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years). | 2014-09-11 |
20140256822 | TRANSMUCOSAL DRUG DELIVERY SYSTEM - Disclosed are preparations and formulations of high thermodynamic activity lipophilic associations (LA), in which there is pairing between an ionizable pharmaceutical agent and a lipophilic species having ionic characteristics opposite to that of the pharmaceutical agent. Such lipophilic associations manifest high thermodynamic activity, as evidenced by their being predominantly in a liquid phase at room temperature or solvated in a lower-than-water dielectric solvent. Further the pharmaceutical agent being solubilized means that dissolution is not rate limiting to transmucosal absorption. This LA or LA-solvate is formulated into a low dielectric dosage form, from whence, upon the dosage form's hydration, the pharmaceutical agent is driven through the mucosal tissue and into systemic circulation. The invention therefore provides an enhanced transmucosal drug delivery system for ionizable pharmaceutical agents at or near physiological pH. | 2014-09-11 |
20140256823 | TRANSMUCOSAL DRUG DELIVERY SYSTEM - Disclosed are preparations and formulations of high thermodynamic activity lipophilic associations (LA), in which there is pairing between an ionizable pharmaceutical agent and a lipophilic species having ionic characteristics opposite to that of the pharmaceutical agent. Such lipophilic associations manifest high thermodynamic activity, as evidenced by their being predominantly in a liquid phase at room temperature or solvated in a lower-than-water dielectric solvent. Further the pharmaceutical agent being solubilized means that dissolution is not rate limiting to transmucosal absorption. This LA or LA-solvate is formulated into a low dielectric dosage form, from whence, upon the dosage form's hydration, the pharmaceutical agent is driven through the mucosal tissue and into systemic circulation. The invention therefore provides an enhanced transmucosal drug delivery system for ionizable pharmaceutical agents at or near physiological pH. | 2014-09-11 |
20140256824 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLOMERULONEPHRITIS - The invention provides compositions and methods for the treatment of glomerulonephritis. In one embodiment, the invention provides a compound of formula (I) | 2014-09-11 |
20140256825 | Methods and Compositions for Deterring Feeding/Repelling the Brown Marmorated Stink Bug (BMSB), Halyomorpha halys - Compositions (feeding deterrent/repellent for | 2014-09-11 |
20140256826 | TOPICAL USE OF AN ANTIMICROBIAL FORMULATION - The present document describes a method of reducing a microbial presence on at least one part of a subject by topically contacting the subject's part with an antimicrobial formulation comprising: a) at least one antimicrobial isolated or synthetic phenolic compound of natural origin; b) at least one surfactant sufficient to form a solution or dispersion of said phenolic compound in an aqueous carrier; c) a solvent for dissolving said phenolic compound; and d) a sufficient aqueous carrier quantity to make 100% (w/w). | 2014-09-11 |
20140256827 | Method Improve Spatial Memory Via Pterostilbene Administration - Disclosed is a pharmaceutical composition for treating oxidative stress comprising a therapeutically effective amount of a substantially pure compound of pterostilbene and a physiologically acceptable carrier. Pterostilbene is administered in an amount between about 2.5 mg to about 10 mg per kilogram of subject body weight. Also disclosed is a method for increasing a working memory of a subject, the method comprising administrating an effective amount of a substantially pure compound of pterostilbene, wherein the working memory for a subject increase and the therapeutic effectiveness is about 10 mg of pterostilbene per kilogram of subject body weight. | 2014-09-11 |
20140256828 | STABLE LIQUID FORMULATIONS OF VOLATILE GAS ANESTHETICS - A stable liquid nanoemulsion of a volatile gas anesthetic, such as, isoflurane or sevoflurane, is disclosed which is effective in inducing and maintaining a state of anesthesia and/or general anesthesia in a patent. A method of preparation of stable liquid formulations of volatile gas anesthetics is presented, as well as a method for directly testing the concentration of a volatile gas anesthetic in a stable liquid formulation. A kit comprising an amount of a stable liquid formulation of a volatile gas anesthetic, and the non-specialized equipment for administration of the same to a patient, either in an operating room environment or in the field, is also described herein. | 2014-09-11 |
20140256829 | Method for Producing Lutein from Tobacco - A method for producing lutein from one or more plants of genus | 2014-09-11 |
20140256830 | RESORCINOL COMPOUNDS FOR DERMATOLOGICAL USE - Provided herein are methods and compositions comprising resorcinol derivatives for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible discontinuities of the skin resulting from skin pigmentation, skin aging, or other disorders are also disclosed. | 2014-09-11 |
20140256831 | HYDROGEL AND METHOD FOR PRODUCING SAME - A hydrogel is provided which is obtained by reacting an azide group and a cyclooctyne group in the absence of a catalyst, especially in the absence of a copper catalyst. The hydrogel has: (a) a first polymer moiety composed of hyaluronic acid, carboxymethyl dextran or the like; (b) a second polymer moiety composed of hyaluronic acid, carboxymethyl dextran or the like, said second polymer moiety being of a kind that is same as or different from the kind of the moiety (a) and is composed of a molecule different from the moiety (a); and (c) a triazole ring group or a derivative group thereof. | 2014-09-11 |
20140256832 | FULLERENE-DERIVED CELLULOSE NANOCRYSTAL, THEIR PREPARATION AND USES THEREOF - The disclosure relates to a fullerene-derived cellulose nanocrystals, process for preparing same and methods of using said nanocrystals. | 2014-09-11 |
20140256833 | MILD LEAVE-ON SKIN CARE COMPOSITIONS - This invention relates to a composition that is mild to the skin containing a cosmetically acceptable oil; water; a cosmetically acceptable emulsifier having an HLB of from about 1 to about 25; and a preservative comprising an organic acid selected from the group consisting of benzoic acid, p-anisic acid, sorbic acid, lactic acid, acetic acid, formic acid, oxalic acid, tartaric acid, salicylic acid and citric acid; wherein said composition has a pH less than 5 and a buffer capacity of between about 0.001 and about 0.039. | 2014-09-11 |
20140256834 | NON-PARTICULATE ORGANIC POROUS MATERIAL HAVING OPTICAL RESOLUTION CAPABILITY AND METHOD FOR MANUFACTURING SAME - A non-particulate organic porous material with optical resolution capability, the non-particulate organic porous material having a continuous pore structure, which comprises macropores and mesopores, the macropores being interconnected forming mesopores with a radius of 0.01-100 μm in the interconnected parts, and optically active groups uniformly introduced therein possesses high physical stability, can be used under wide separating conditions, and has a large capacity for separating optically active substances (enantiometers). | 2014-09-11 |
20140256835 | Polyetherimide/ poly(biphenyl ether sulfone) foam materials - A foam material made from a composition (C) comprising a polyetherimide (PEI) and a poly(biphenyl ether sulfone) (P2). | 2014-09-11 |
20140256836 | PROCESS FOR THE PREPARATION OF MONODISPERSE POLYMER PARTICLES - A process for the preparation of monodisperse polymer particles which are formed by contacting monomers with aqueous dispersions comprising monodisperse swellable seed polymers/oligomers, and initiating polymerization in the presence of a steric stabilizer. The resulting swollen seed particles are characterized by the particle mode diameter. | 2014-09-11 |
20140256837 | HYDROGELS THAT UNDERGO VOLUMETRIC EXPANSION IN RESPONSE TO CHANGES IN THEIR ENVIRONMENT AND THEIR METHODS OF MANUFACTURE AND USE - Hydrogels are described that expand volumetrically in response to a change in their environment and as well as their methods of manufacture and use. | 2014-09-11 |
20140256838 | WETTABLE, HIGH STRENGTH FOAM ESPECIALLY FOR INK HOLDERS - A wettable, high strength, ether foam, particularly suited for ink holders, that includes a prepolymer that is formed before adding it to other components in the foam formulation. | 2014-09-11 |
20140256839 | POLYBUTADIENE MODIFIED POLYMER POLYOLS, FOAMS PREPARED FROM POLYBUTADIENE MODIFIED POLYMER POLYOLS, AND PROCESSES FOR THE PRODUCTION THEREOF - This invention relates to polybutadiene modified polymer polyols which comprise one or more base polyols, at least one preformed stabilizer, one or more ethylenically unsaturated monomers, and polybutadiene, in the presence of at least one free radical polymerization catalyst, and optionally, one or more chain transfer agents. The polybutadiene present in these polybutadiene modified polymer polyols may be carried into the polymer polyol through the preformed stabilizer, by a polybutadiene containing component that is added separately from the preformed stabilizer to the polymer polyol, or a combination thereof, with the total amount of polybutadiene ranging from 0.03 to 1.0% by weight of polybutadiene, based on 100% by weight of the polymer polyol. The present invention also relates to processes for preparing these polybutadiene modified polymer polyols, to foams prepared from these polybutadiene modified polymer polyols, and to processes for producing foams from these polybutadiene modified polymer polyols. | 2014-09-11 |
20140256840 | CARBON NANOTUBE (CNT) MATERIALS HAVING INCREASED THERMAL AND ELECTRICAL CONDUCTIVITY - A structure having a carbon nanotube material having a plurality of carbon nanotubes and an electrically or thermally conductive material disposed on at least a portion of the carbon nanotubes, such electrically or thermally conductive material being chemically bonded to such portion of the carbon nanotubes. | 2014-09-11 |
20140256841 | COMPOSITION FOR FORMING ELECTRONIC PAPER WITHOUT PARTICLE FREEZING, AND ADHESIVE FILM PREPARED THEREBY - Disclosed is a sealing film for electronic paper having a multilayered structure. The multilayered film for electronic paper comprising a layered structure according to the present invention comprises: (a) a sealing layer formed with a material comprising a UV curable polymer resin composition or a UV transmitting polymer resin composition; and (b) a tack-free adhesive layer formed with a material comprising a UV curable polymer resin. The sealing film has excellent sealing properties and is tack-free at room temperature, and thus it is possible to minimize freezing of electrostatic particles inside a microcup sticking to the surface of a sealing material during manipulation thereof. | 2014-09-11 |
20140256842 | Method For Producing Optical Member And Use Of UV-Curable Resin Composition Therefor - The present invention relates to a method for producing an optical member wherein an optical substrate having a light-blocking part on the surface is bonded to an optical substrate for bonding. The method for producing an optical member uses a UV-curable resin composition and comprises specific (Process 1) through (Process 3). The present invention also relates to the use of a UV-curable resin composition comprising a (meth)acrylate (A) and a photopolymerization initiator (B) for the production method, and a UV-curable resin composition. It is possible to produce a bonded optical member having good curability and adhesiveness, such as a touch panel or display unit having an optical substrate comprising a light-blocking part, with good productivity but with little damage to the optical substrate. It is thereby possible to obtain an optical member having a high degree of resin curing at the light-blocking part and high reliability. | 2014-09-11 |
20140256843 | BIOMATERIAL FOR OSTEOSYNTHESIS - A biomaterial for the manufacture of osteosynthesis articles is provided. The biomaterial contains a semi-aromatic polyamide matrix along with a reinforcing means selected to reinforce the matrix. The biomaterial has dynamic mechanical properties analogous to calcified tissue. | 2014-09-11 |
20140256844 | NOVEL SILICONE POLYETHER COPOLYMERS AND PROCESS FOR PREPARATION THEREOF - Novel silicone polyether copolymers of inverse structure of the formula 1, characterized in that no unsaturated functional groups caused by side reactions or conversion products thereof are present in the copolymer, and a process for preparation thereof, in which a polyether modified terminally and/or laterally with alkoxysilyl groups is reacted with silanes and/or siloxanes which bear one or more hydrolysis-labile groups, in a hydrolysis and condensation reaction. | 2014-09-11 |
20140256845 | METHOD FOR PREPARING A MASTERBATCH OF NATURAL RUBBER AND MAGNESIUM-DOPED SILICA - Method for preparing a silica/natural rubber masterbatch, including: doping the silica with magnesium; preparing at least one dispersion of the resulting doped silica in water; bringing a natural rubber field latex into contact with the aqueous doped-silica dispersion and mixing them together so as to obtain a coagulum; recovering the coagulum; and drying the recovered coagulum so as to obtain the masterbatch. | 2014-09-11 |
20140256846 | ELASTOMER COMPOSITION HAVING A VERY GOOD DISPERSION OF THE CHARGE IN THE ELASTOMER MATRIX - The invention relates to a rubber composition based on at least one diene elastomer, a reinforcing filler including at least carbon black, having a specific surface area CTAB greater than or equal to 130 m | 2014-09-11 |
20140256847 | RUBBER COMPOSITION, AND PNEUMATIC TIRE - Provided are a rubber composition achieving balanced improvement in processability, fuel economy, rubber strength, abrasion resistance, wet-grip performance, and handling stability, and a pneumatic tire including the composition. The rubber composition includes, per 100% by mass of a rubber component, at least 35% by mass of SR, the composition including a conjugated diene polymer and a silica having N | 2014-09-11 |
20140256848 | IMPACT-MODIFIED POLYCARBONATE/POLYESTER OR POLYCARBONATE/POLYAMIDE COMPOSITIONS - The invention relates to impact-modified polymer compositions, containing a polymer blend of polycarbonate with polyester and/or polyamide, plus an impact modifier blend of core/shell and functional polyolefin impact modifiers. The impact modifiers can provide the polymer blend composition with improved impact strength at equivalent loading, and also allow for higher amounts of polyester and/or polyamide in the blend without sacrificing impact strength. | 2014-09-11 |
20140256849 | SILICATE ENCLOSED PIGMENT PARTICLES - Disclosed is a silicate-enclosed pigment composition comprising hollow silicate shells each defining a core and pigment particles received in the cores. Silicate-enclosed pigments may be produced by dispersing pigment particles in an aqueous solution of an alkali silicate and spray drying the dispersion to yield a plurality of silicate shells each defining a hollow core, wherein the pigment particles are received within the hollow cores. | 2014-09-11 |
20140256850 | COMPOSITE MATERIAL VIA IN-SITU POLYMERIZATION OF THERMOPLASTIC (METH)ACRYLIC RESINS AND ITS USE - The present invention relates to a composite material obtained by in situ polymerization of a thermoplastic resin with a fibrous material. More particularly the present invention relates to a polymeric composite material obtained by in-situ polymerization of a thermoplastic (meth) acrylic resin and a fibrous material containing long fibers and its use, a process for making such a composite material and manufactured mechanical or structured part or article comprising this polymeric composite material. | 2014-09-11 |
20140256851 | METHOD FOR REDUCING ODORIFEROUS AND/OR TOXIC RESIDUAL MONOMER IN A LATEX - The present invention relates to a new and efficient toxicity and/or odor reducing method for ethyl acrylate and/or acrylonitrile contained aqueous polymer dispersion. | 2014-09-11 |
20140256852 | WATER BORNE EPOXY RESIN DISPERSIONS AND EPOXY HARDENER COMPOSITIONS - An epoxy or hardener mixture comprising (a) optionally water, (b) at least one hardener or epoxy resin, and (c) from 0.1 to 20 weight percent, based on epoxy resin of at least one distyryl phenol, tristyryl phenol or cumylphenol based additive surfactant with phosphate or sulfonate end groups having the structure R—OXn-W wherein R designates a polystyrylphenol or cumylphenol, preferentially chosen from among distyrylphenol, tristyrylphenol or cumylphenol, and mixtures thereof, and wherein OX designates ethylene oxide and/or propylene oxide. The number of groups “n” varies from 0 to 200, and W designates H, sulfate (—SO | 2014-09-11 |
20140256853 | Curing Agent for Low Temperature Cure Applications - The present invention provides Mannich base derivatives of N,N′-dimethyl secondary diamine polymers including Mannich base derivatives of methylamine-terminated poly-(N-methylazetidine) and Mannich base derivatives of methylamine-terminated poly-(N-methylazacycloheptane). Amine curing agent compositions and amine-epoxy compositions containing Mannich base derivatives of N,N′-dimethyl secondary diamine polymers are also disclosed. | 2014-09-11 |
20140256854 | FLUORINATED WATER-OIL REPELLENCY AGENTS - The present invention relates to an active energy ray curable compound (A) comprising: at least one (poly)lactone-containing moiety (a1), at least one fluorine-containing moiety (a3), and at least one further moiety (a2) present between moieties (a1) and (a3). The invention further relates to ways of making such compounds and to their use in providing water-oil repellency properties to a coating composition. | 2014-09-11 |
20140256855 | CARBON FIBER SIZING AGENT, AQUEOUS DISPERSION THEREOF, CARBON FIBER BUNDLE APPLIED WITH SIZING AGENT, SHEET-LIKE ARTICLE COMPRISING CARBON FIBER BUNDLE... - The present invention provides: a carbon fiber sizing agent that can obtain a carbon fiber bundle having a superior effect of improving mechanical properties when composited using a resin; an aqueous dispersion thereof; a carbon fiber bundle; a sheet-shaped article having a carbon fiber bundle; and a composite material. The carbon fiber sizing agent contains: a compound (A) that is an ester of an unsaturated monobasic acid and an epoxy compound having a plurality of epoxy groups in the molecule, and that has at least one epoxy group in the molecule; a urethane acrylate oligomer (B) that is bifunctional and that has a tensile elongation rate of the cured product of at least 40%; and a polyurethane resin (C) having a tensile elongation rate of a dried coating film of 350-900% inclusive. The amounts of A-C contained satisfy the conditions described in the description. The aqueous dispersion disperses the sizing agent. The carbon fiber bundle contains 0.6-3.0 mass % inclusive of the sizing agent. The sheet-shaped article and a pultruded composite material contain the carbon fiber bundle. The composite material contains the sheet-shaped article. | 2014-09-11 |
20140256856 | LIQUID EPOXY RESIN FORMULATIONS - A liquid epoxy resin composition having a reduced tendency to crystallize including at least one liquid epoxy resin having the following generic chemical Structure (I): where n is 0 or an integer of 1 or more; and wherein n=0 is in the range of between about 1 wt % and about 90 wt %; wherein; n=1 is in the range of between about 7 wt % and about 20 wt %; n=2 is in the range of between about 0.8 wt % and about 3 wt %; and n=3 and above is in the range of about 0 wt % and about 2 wt %. | 2014-09-11 |
20140256857 | POLYCARBOXYLATE ETHERS WITH BRANCHED SIDE CHAINS - A method of utilizing a copolymer for dispersing inorganic binders, the copolymer comprising as comonomers in copolymerized form at least one ethylenically unsaturated acid monomer and at least one ethylenically unsaturated, branched polyether macromonomer. Further disclosed are dispersants for inorganic binders, comprising the subject copolymer, and building material mixtures comprising inorganic binders and the subject dispersant. | 2014-09-11 |
20140256858 | SOLUTION POLYMERIZATION PREPARED STYRENE/BUTADIENE ELASTOMER CONTAINING LIQUID STYRENE/BUTADIENE POLYMER AND TIRE WITH COMPONENT - The invention relates to preparation and use of organic solvent solution polymerization-prepared styrene/butadiene elastomers, particularly high molecular weight styrene/butadiene elastomers which are extended by an inclusion of a liquid styrene/butadiene polymer. The invention also relates to a tire having a component comprised of a rubber containing such extended styrene/butadiene elastomer. | 2014-09-11 |
20140256859 | WOOD MATERIAL PRODUCT AND METHOD FOR THE PRODUCTION THEREOF - The invention relates to a wood material product and a method for producing wood material products from particles containing lignocellulose and adhesives containing formaldehydes, which are intermixed and fed to a forming process after mixing. A zeolite is added to the mixture of adhesives and particles containing lignocellulose. | 2014-09-11 |
20140256860 | SHORT OIL ALKYD RESIN DISPERSION FOR INDUSTRIAL COATING COMPOSITIONS - The present disclosure provides for an aqueous solvent-free short oil alkyd resin dispersion and a process for producing the same. The aqueous solvent-free short oil alkyd resin dispersion, according to the present disclosure comprises from 35 to 65 percent by weight of a short oil alkyd resin based on the total weight of the dispersion, where the short oil alkyd resin has a weight average molecular weight (Mw) in the range of 5,000 to 5,000,000 Dalton and a volume average particle size diameter in the range of 0.05 to 1.0 μm; 0.1 to 6 percent by weight of a surfactant, based on the total weight of the dispersion; and 29 to 65 percent by weight of water, based on the total weight of the dispersion, where the aqueous solvent-free short oil alkyd resin dispersion does not include a solvent. | 2014-09-11 |
20140256861 | HALOGEN FREE FLAME RETARDED POLYCARBONATE - The present invention provides a flame-retardant thermoplastic molding composition made from an aromatic polycarbonate, an impact modifier, a bisphenol-A oligophosphate and glass fibers, wherein the ratio of polycarbonate to bisphenol-A oligophosphate is less than about 7.5, wherein the ratio of glass fibers to bisphenol-A oligophosphate is less than about 2.5, wherein the composition is rated V0 at 1.5 mm according to UL-94, and wherein the composition is free from halogenated flame retardants. | 2014-09-11 |
20140256862 | ADDITIVES TO IMPROVE OPEN-TIME AND FREEZE-THAW CHARACTERISTICS OF WATER-BASED PAINTS AND COATINGS - Waterborne coatings are described having an acceptable balance of properties both during the storage of coating, application and drying. The period in which irregularities in a freshly applied coating can be repaired without resulting in brush marks is referred to as the open time. Aqueous coatings generally employ dispersed high molecular weight polymers as binders. These binders often provide short open times when the coating is dried since the dispersed polymer particles tend to be immobilized quickly in the edge region of an applied coating. As a result, the viscosity of the coating increases rapidly, which leads to a limited window of workability. The instant invention provides additives that are not volatile but that will extend the time that the film is malleable after after it is applied without interfering with other attributes, such as the resistance of the coating to freezing while in the can prior to application. | 2014-09-11 |
20140256863 | SLURRY COMPOSITION, CERAMIC GREEN SHEET, AND MULTI LAYER CERAMIC CAPACITOR - To provide a slurry composition by which a ceramic green sheet to be obtained has sufficient mechanical strength and has little dimensional change during storage and ply separation is less prone to occur at the beginning of degreasing. | 2014-09-11 |
20140256864 | POLYPHENYLENE SULFIDE RESIN COMPOSITION, PRODUCTION METHOD THEROF AND MOLDED PRODUCT THEROF (AS AMENDED) - There is provided a polyphenylene sulfide (PPS) resin composition, comprising: 5 to 50 parts by weight of a polyamide resin (b) and 50 to 250 parts by weight of a metal hydroxide (c) relative to 100 parts by weight of a polyphenylene sulfide resin (a), wherein the metal hydroxide is dispersed in the composition at an average secondary particle diameter equal to or less than 5 μm. The PPS resin composition may provide excellent tracking resistance without significantly damaging various intrinsic properties of a PPS resin, such as excellent mechanical strength and low gas generation. | 2014-09-11 |
20140256865 | ELECTRIC-ARC RESISTANT FACE SHIELD OR LENS INCLUDING IR-BLOCKING INORGANIC NANOPARTICLES - A transparent electric-arc resistant composition is produced by preparing crystalline tungsten bronze nanoparticles and homogenously dispersing the nanoparticles in a transparent plastic matrix. The crystalline tungsten bronze nanoparticles are prepared by homogeneously mixing an aqueous solution of soluble tungsten and cesium salts and then drying the solution. The dried solution is then heated in a reducing gas or inert gas atmosphere to form crystalline tungsten bronze nanoparticles. Thereafter, a dispersion agent is added and the nanoparticles are dispersed in a liquid solvent medium by wet milling to form a dispersion mixture. The dispersion mixture is then mixed with polymer pellets to form a polymer mixture, and the polymer mixture is then extruded to yield polymer pellets containing highly homogeneously dispersed inorganic nanoparticles. During or after dispersion, additional particles, dyes, heat stabilizers or UV absorbers, may be added. A lens or shield is then molded from the polymer pellets. | 2014-09-11 |
20140256866 | Synthetic Megakalsilite via Hydrothermal Preparation - This invention relates to megakalsilite platelets, methods of hydrothermally forming said platelets and the megakalsilite platelets obtainable via the disclosed hydrothermal method. More specifically the disclosure describes an improved hydrothermal synthesis of megakalsilite platelets, which are suitable as platelet for interference pigments, and in barrier and flame retardant applications. | 2014-09-11 |
20140256867 | PSA CONTAINING OLEFIN BLOCK COPOLYMERS AND STYRENE BLOCK COPOLYMERS - The invention relates to storage-stable hot-melt adhesive containing 15 to 70 wt % of a mixture of at least one copolymer based on ethylene and/or propylene and at least one C4 to C20 α-olefin which is obtainable as a block copolymer by metallocene-catalysed polymerisation, and at least one styrene block copolymer, 10 to 70 wt % of at least one tackifying resin, 0 to 40 wt % of further additives, wherein the total of the percentages should amount to 100% and the tackifying resin is entirely or in part a soft resin. | 2014-09-11 |
20140256868 | HIGH BLOCK, TACK AND SCRUB RESISTANT POLYMER - The present invention is directed to a coating composition or paint comprising a multistage latex with at least first and second stages, wherein the composition or paint is substantially free of volatile organic compounds (VOC) and capable of film formation even in the absence of coalescent agents. The base paint formulation is capable of being tinted at a point-of-sale (i.e. in-store) using a colorant composition of a type and quantity required to produce a paint of desired color and finish. The paints, including deeply colored paints, show improved block resistance, scrub resistance and tack resistance. | 2014-09-11 |
20140256869 | PROPYLENE POLYMER COMPOSITION AND MOLDED ARTICLE THEREOF - The present invention provides a propylene polymer molded article being high in tensile elongation and scratch resistance and a propylene polymer composition capable of affording such a molded article. Specifically, the present invention provides, in one embodiment thereof, a propylene polymer composition comprising a propylene polymer (A-1) that is a polymer having an intrinsic viscosity, as measured in tetralin at 135° C., of from 1.2 dl/g, inclusive, to 1.7 dl/g, exclusive, or a propylene polymer (A-2) that is a polymer having an intrinsic viscosity, as measured in tetralin at 135° C., of from 1.7 dl/g, inclusive, to 2.9 dl/g, inclusive, a propylene polymer (B) that is a polymer having an intrinsic viscosity, as measured in tetralin at 135° C., of from 0.5 dl/g, inclusive, to 1.1 dl/g, exclusive, and a nucleating agent. | 2014-09-11 |
20140256870 | COMPOSITION AND FILM COMPRISING SAME - The present invention provides: a composition including a polymer (i) which has a —SO | 2014-09-11 |